Who is sponsoring NCT04189250?

NCT04189250 is sponsored by Swiss Federal Institute of Sport Magglingen.

What drugs are being tested in NCT04189250?

Interventions in NCT04189250: Automatized carbonmonoxide rebreathing machine - OpCO Detalo instruments.

What condition does NCT04189250 study?

NCT04189250 studies Hemoglobins.

Is NCT04189250 still recruiting?

NCT04189250 is currently status unknown. Last updated 11 March 2020.

Last reviewed 2020-03-11 · How we verify

NCT04189250

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of the Automatized and the Optimized Carbon Monoxid Rebreathing Protocol

Status unknown NA Last updated 11 March 2020

What this trial tests

NA trial testing Automatized carbonmonoxide rebreathing machine - OpCO Detalo instruments in Hemoglobins in 31 participants. Status unknown.

Timeline

20 January 2020

Primary endpoint
20 April 2020

1 August 2020

Quick facts

Lead sponsor	Swiss Federal Institute of Sport Magglingen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	31
Start date	20 January 2020
Primary completion	20 April 2020
Estimated completion	1 August 2020
Sites	1 location across Switzerland

Drugs / interventions tested

Automatized carbonmonoxide rebreathing machine - OpCO Detalo instruments

Conditions studied

Hemoglobins — all drugs for Hemoglobins →

Sponsor

Swiss Federal Institute of Sport Magglingen

Who can join

18 and older, any sex, with Hemoglobins. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is the comparison of two measurement protocols determining hemoglobin mass with two different blood sampling strategies.Both protocols are based on the principle of the carbonmonoxid (CO) rebreathing method. During this measurement, CO is inhaled for a specific time period by the subject in a closed circuit and it is used as a marker to tag circulating hemoglobin.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Swiss Federal Institute of Sport Magglingen trials

Trials by the same sponsor.

NCT06944574 — Sleep Intervention Swiss Elite Athletes · NA · completed
NCT04849923 — Validation of a Digital Twin Performing Strength Training · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04189250 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Swiss Federal Institute of Sport Magglingen
Last refreshed: 11 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04189250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing